Adenosine A2breceptors control A1receptor‐mediated inhibition of synaptic transmission in the mouse hippocampus
Authors:
- Francisco Q. GonçalvesFGFrancisco Q. Gonçalves
- Johny PiresJPJohny Pires
- Anna PliassovaAPAnna Pliassova
- Cristina LemosCLCristina Lemos
- Joana M. MarquesJMJoana M. Marques
- Ricardo J. RodriguesRicardo J. Rodrigues
- Paula M. CanasPCPaula M. Canas
- Attila KöfalviAKAttila Köfalvi
- Rodrigo A. CunhaRodrigo A. Cunha
- Daniel RialDRDaniel Rial
- 19 February 2015
- journal article
- Published by Wiley in European Journal of Neuroscience
- Vol. 41 (7) , 878-888
Abstract
Adenosine is a neuromodulator mostly acting through A1(inhibitory) and A2A(excitatory) receptors in the brain. A2Breceptors (A2BR) are Gs/q‐protein‐coupled receptors with low expression in the brain. As A2BRfunction is largely unknown, we have now explored their role in the mouse hippocampus. We performed electrophysiological extracellular recordings in mouse hippocampal slices, and immunological analysis of nerve terminals and glutamate release in hippocampal slices and synaptosomes. Additionally, A2BR‐knockout (A2BR‐KO) and C57/BL6 mice were submitted to a behavioural test battery (open field, elevated plus‐maze, Y‐maze). The A2BRagonistBAY60‐6583 (300 nm) decreased the paired‐pulse stimulation ratio, an effect prevented by the A2BRantagonistMRS 1754 (200nM) and abrogated in A2BR‐KOmice. Accordingly, A2BRimmunoreactivity was present in 73 ± 5% of glutamatergic nerve terminals, i.e. those immunopositive for vesicular glutamate transporters. Furthermore,BAY 60‐6583 attenuated the A1R control of synaptic transmission, both the A1R inhibition caused by 2‐chloroadenosine (0.1–1 μm) and the disinhibition caused by the A1R antagonistDPCPX(100 nm), both effects prevented byMRS 1754 and abrogated in A2BR‐KOmice.BAY 60‐6583 decreased glutamate release in slices and also attenuated the A1R inhibition (CPA100 nm). A2BR‐KOmice displayed a modified exploratory behaviour with an increased time in the central areas of the open field, elevated plus‐maze and the Y‐maze and no alteration of locomotion, anxiety or working memory. We conclude that A2BRare present in hippocampal glutamatergic terminals where they counteract the predominant A1R‐mediated inhibition of synaptic transmission, impacting on exploratory behaviour.Keywords
This publication has 81 references indexed in Scilit:
- Cardiovascular adenosine receptors: Expression, actions and interactionsPharmacology & Therapeutics, 2013
- Functional interaction between pre‐synaptic α6β2‐containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatumBritish Journal of Pharmacology, 2013
- Adenosine A2B receptor-mediated leukemia inhibitory factor release from astrocytes protects cortical neurons against excitotoxicityJournal of Neuroinflammation, 2012
- Adenosine receptors and brain diseases: Neuroprotection and neurodegenerationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2011
- Adenosine A2A Receptor Is Involved in Cell Surface Expression of A2B ReceptorJournal of Biological Chemistry, 2010
- A2badenosine receptors can change their spotsBritish Journal of Pharmacology, 2010
- A2B adenosine receptor dampens hypoxia-induced vascular leakBlood, 2008
- Adenosine A2A Receptors Are Essential for Long-Term Potentiation of NMDA-EPSCs at Hippocampal Mossy Fiber SynapsesNeuron, 2008
- Adenosine A2b Receptors Mediate an Increase in Interleukin (IL)‐6 mRNA and IL‐6 Protein Synthesis in Human Astroglioma CellsJournal of Neurochemistry, 1996
- Desensitization and internalization of adenosine A1 receptors in rat brain by in vivo treatment with R-PIA: involvement of coated vesiclesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996